115 related articles for article (PubMed ID: 7911985)
21. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
[TBL] [Abstract][Full Text] [Related]
22. Infusions of tyrosine hydroxylase antisense oligodeoxynucleotide into substantia nigra of the rat: effects on tyrosine hydroxylase mRNA and protein content, striatal dopamine release and behaviour.
Skutella T; Schwarting RK; Huston JP; Sillaber I; Probst JC; Holsboer F; Spanagel R
Eur J Neurosci; 1997 Feb; 9(2):210-20. PubMed ID: 9058042
[TBL] [Abstract][Full Text] [Related]
23. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
Bowery B; Rothwell LA; Seabrook GR
Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
[TBL] [Abstract][Full Text] [Related]
24. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
Mavridis M; Besson MJ
Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
[TBL] [Abstract][Full Text] [Related]
25. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
Sirinathsinghji DJ; Schuligoi R; Heavens RP; Dixon A; Iversen SD; Hill RG
Neuroscience; 1994 Sep; 62(2):407-23. PubMed ID: 7830888
[TBL] [Abstract][Full Text] [Related]
26. Acute methamphetamine administration increases tyrosine hydroxylase mRNA levels in the rat locus coeruleus.
Shishido T; Watanabe Y; Matsuoka I; Nakanishi H; Niwa S
Brain Res Mol Brain Res; 1997 Dec; 52(1):146-50. PubMed ID: 9450687
[TBL] [Abstract][Full Text] [Related]
27. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine.
Rodríguez-Gómez JA; Romero-Ramos M; Vizuete ML; Venero JL; Cano J; Machado A
Mol Pharmacol; 1997 Oct; 52(4):641-7. PubMed ID: 9380027
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
29. Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat.
Levinson AJ; Garside S; Rosebush PI; Mazurek MF
Neuroscience; 1998 May; 84(1):201-11. PubMed ID: 9522374
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of nigral dopamine neurons by systemic and local apomorphine: possible contribution of dendritic autoreceptors.
Akaoka H; Charléty P; Saunier CF; Buda M; Chouvet G
Neuroscience; 1992 Aug; 49(4):879-91. PubMed ID: 1359456
[TBL] [Abstract][Full Text] [Related]
31. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
Wang X; Yang HA; Wang XN; Du YF
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
[TBL] [Abstract][Full Text] [Related]
32. Dopamine and GABA receptors in cultured substantia nigra neurons: correlation of electrophysiology and immunocytochemistry.
Kim KM; Nakajima S; Nakajima Y
Neuroscience; 1997 Jun; 78(3):759-69. PubMed ID: 9153656
[TBL] [Abstract][Full Text] [Related]
33. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
34. Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata.
Hatzipetros T; Raudensky JG; Soghomonian JJ; Yamamoto BK
J Neurosci; 2007 May; 27(22):5895-902. PubMed ID: 17537960
[TBL] [Abstract][Full Text] [Related]
35. Gabaergic transmission and tyrosine hydroxylase expression in the nigral dopaminergic neurons: an in vivo study using a reversible ischemia model of rats.
Yamada K; Goto S; Yoshikawa M; Ushio Y
Neuroscience; 1996 Aug; 73(3):783-9. PubMed ID: 8809797
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine hydroxylase mRNA in the dopaminergic neurons of young adult and aged mice by in situ hybridization.
Gupta M; Stoler MH; Fossom LH; Tank AW
Neurosci Lett; 1990 Oct; 119(1):49-52. PubMed ID: 1982959
[TBL] [Abstract][Full Text] [Related]
37. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat.
González-Hernández T; Rodríguez M
J Comp Neurol; 2000 May; 421(1):107-35. PubMed ID: 10813775
[TBL] [Abstract][Full Text] [Related]
38. Localization of GABA transaminase immunoreactivity in the rat substantia nigra pars reticulata.
Yung KK; Tse YC; Gao ZG; Choi SY; Kwok FS
Neurosci Lett; 1998 Aug; 253(1):57-60. PubMed ID: 9754804
[TBL] [Abstract][Full Text] [Related]
39. Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta.
Jang JY; Jang M; Kim SH; Um KB; Kang YK; Kim HJ; Chung S; Park MK
J Neurochem; 2011 Mar; 116(6):966-74. PubMed ID: 21073466
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
Waszczak BL
Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
